Author:
Sarnpitak Pakornwit,Mujumdar Prashant,Morisseau Christophe,Hwang Sung Hee,Hammock Bruce,Iurchenko Vladimir,Zozulya Sergey,Gavalas Antonis,Geronikaki Athina,Ivanenkov Yan,Krasavin Mikhail
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference54 articles.
1. The development of COX-2 inhibitors;Flower;Nat. Rev. Drug. Discov.,2003
2. The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor;Prasit;Bioorg. Med. Chem. Lett.,1999
3. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3- (trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, celecoxib);Penning;J. Med. Chem.,1997
4. Analysts Rx Product Desk Reference,2001
5. Cyclooxygenase inhibitors – current status and future prospects;Dannhardt;Eur. J. Med. Chem.,2001
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献